Effectiveness of Physical Exercise of Patients With Chronic Non-communicable Disease
NCT Number: NCT06476015
Status: RECRUITING
Study Type: OBSERVATIONAL
Conditions: COPD|Diabetes|Physical Inactivity|Frailty
Interventions: OTHER: Therapeutic exercise
Sponsor: Fundacion Universitaria Maria Cano
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 300
Study Design: Observational Model: |Time Perspective: p
Start Date: 2024-01-01
Completion Date: 2024-12-30
Locations: Fundación Universitaria María cano, Medellin, Antioquia, 05000, Colombia

Summary:
According to the Pan American Health Organization (PAHO), chronic, non-communicable diseases (NCDs) are the main cause of death and disability in the world. The term, NCD refers to a group of diseases that are not primarily caused by acute infection and result in long-lasting health consequences, with significant long-term care and treatment needs. These include chronic lung diseases such as COPD and metabolic diseases such as Diabetes. Worldwide, chronic non-communicable diseases are related to physical inactivity as the main risk factor. In this sense, exercise and physical activity have become priority elements of public health, with recommendations that they be carried out with moderate intensity at least 150 minutes a week. In Colombia, exercise as an important strategy for the prevention and management of chronic non-communicable diseases, which is described in the ten-year public health plan. However, in its application in clinical practice, the evidence shows that there are few structured programs at the national or regional level, which monitor the adequate prescription of exercise as a therapeutic strategy for the control of NCDs and improvement. of functionality. Reason for which this research arises, which aims to describe the effectiveness of exercise on the frailty, body composition and functional classification of 300 patients with chronic non-communicable disease.

Primary Outcome Measures: Frailty, The data will be collected from the clinical registries which have included The Groeningen frailty test, walking speed test and single-leg support test. These variables were measured by groningen frailty indicator questionnaire. This scale categorizes patients with significant frailty when they obtain a score ≥ 4. In addition, the walking speed in 5 meters will also be taken into account, which is considered in fragility cut from 0.6 m/sec and the single-leg support time when it is \< 10 seconds.

This outcome is compound by multiple measurements that will be aggregated to arrive at one reported., 2018-2023
Secondary Outcome Measures: Body composition, The data will be collected from the clinical registries which have included anthropometric measurements such us Body mass index, skin folds (tricipital, abdominal and mid-thigh), waist and thigh circumference. Obesity is present when the sum of the three skin folds of fat is greater than 60 mm. This outcome is compound by multiple measurements that will be aggregated to arrive at one reported., 2018-2023|Cardiovascular capacity, The data will be collected from the clinical registries which have included the National Aeronautics and Space Administration (NASA) method which calculates the Vo2 max and Mets, The formula includes sex, age, BMI, Resting heart rate and physical activity coefficient self-reported. Taking as a reference that a poor physical condition occurs when the estimated maximum oxygen consumption is less than 7 units of the basal metabolic rate. This outcome is compound by multiple measurements that will be aggregated to arrive at one reported., 2018-2023
Other Outcome Measures: Functional classification, The data will be collected from the clinical registries which have included the functional classification. Patients were stratified according to a FC method based on functional status, presence of risk factors, and comorbidity control. There are five possible categories: i) class 1, preserved functional status with controlled comorbidity; ii) class 2A, preserved functional status with controlled comorbidity, but with the presence of risk factors; iii) class 2B, preserved functional status with uncontrolled comorbidity; iv) class 3, altered functional status with uncontrolled comorbidity; and v) class 4, lost functional status with uncontrolled comorbidity. This outcome is compound by multiple measurements that will be aggregated to arrive at one reported., 2018-2023